Ionis Pharmaceuticals Inc (IONS)
41.59
-0.25
(-0.60%)
USD |
NASDAQ |
Apr 26, 16:00
41.58
-0.01
(-0.02%)
After-Hours: 20:00
Ionis Pharmaceuticals Cash from Investing (Quarterly): -26.71M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -26.71M |
| September 30, 2023 | 68.71M |
| June 30, 2023 | 69.52M |
| March 31, 2023 | -325.64M |
| December 31, 2022 | 212.15M |
| September 30, 2022 | -183.93M |
| June 30, 2022 | -3.304M |
| March 31, 2022 | -287.55M |
| December 31, 2021 | 95.11M |
| September 30, 2021 | 121.97M |
| June 30, 2021 | -101.03M |
| March 31, 2021 | 78.86M |
| December 31, 2020 | 187.85M |
| September 30, 2020 | 101.94M |
| June 30, 2020 | 79.70M |
| March 31, 2020 | -95.01M |
| December 31, 2019 | 138.19M |
| September 30, 2019 | 1.396M |
| June 30, 2019 | -110.69M |
| March 31, 2019 | -70.17M |
| December 31, 2018 | -326.21M |
| September 30, 2018 | -307.67M |
| June 30, 2018 | -375.17M |
| March 31, 2018 | 79.49M |
| December 31, 2017 | -54.21M |
| Date | Value |
|---|---|
| September 30, 2017 | -150.10M |
| June 30, 2017 | 14.70M |
| March 31, 2017 | -168.68M |
| December 31, 2016 | 20.80M |
| September 30, 2016 | -57.09M |
| June 30, 2016 | 53.46M |
| March 31, 2016 | 39.43M |
| December 31, 2015 | 27.96M |
| September 30, 2015 | -29.28M |
| June 30, 2015 | -95.39M |
| March 31, 2015 | 36.65M |
| December 31, 2014 | -50.79M |
| September 30, 2014 | -24.49M |
| June 30, 2014 | -32.39M |
| March 31, 2014 | 24.82M |
| December 31, 2013 | -85.27M |
| September 30, 2013 | -123.31M |
| June 30, 2013 | -31.84M |
| March 31, 2013 | -15.31M |
| December 31, 2012 | 5.035M |
| September 30, 2012 | -10.61M |
| June 30, 2012 | 24.09M |
| March 31, 2012 | -0.522M |
| December 31, 2011 | 32.37M |
| September 30, 2011 | -5.702M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-325.64M
Minimum
Mar 2023
212.15M
Maximum
Dec 2022
1.133M
Average
68.71M
Median
Sep 2023
Cash from Investing (Quarterly) Benchmarks
| Madrigal Pharmaceuticals Inc | -362.12M |
| Viking Therapeutics Inc | -459.79M |
| Alnylam Pharmaceuticals Inc | -240.66M |
| Akero Therapeutics Inc | 12.79M |
| 89bio Inc | -63.64M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 32.86M |
| Cash from Financing (Quarterly) | 40.72M |
| Free Cash Flow | -335.52M |
| Free Cash Flow Per Share (Quarterly) | 0.229 |
| Free Cash Flow to Equity (Quarterly) | 29.52M |
| Free Cash Flow to Firm (Quarterly) | 108.04M |
| Free Cash Flow Yield | -5.63% |